Hormonal risk factors and breast cancer prognosis and survival by PAM50 molecular subtype.

被引:0
|
作者
Kwan, Marilyn L. [1 ]
Sweeney, Carol [2 ]
Habel, Laurel A. [1 ]
Weltzien, Erin [1 ]
Castillo, Adrienne [1 ]
Davis, Carole [2 ]
Factor, Rachel E. [2 ]
Kroenke, Candyce H. [1 ]
Shakespear, Kaylynn [2 ]
Quesenberry, Charles P. [1 ]
Stijleman, Inge J. [2 ]
Bernard, Philip S. [2 ]
Kushi, Lawrence H. [1 ]
Caan, Bette J. [1 ]
机构
[1] Kaiser Permanente No Calif, Oakland, CA USA
[2] Univ Utah, Salt Lake City, UT USA
关键词
D O I
10.1158/1538-7445.AM2013-LB-29
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB29
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The Impact of Primary Tumor Resection on the Survival of Patients with Stage IV Breast Cancer According to Molecular Subtype.
    Ahn, S. K.
    Moon, H-G
    Kim, J. S.
    You, J. M.
    Shin, H. C.
    Han, W.
    Noh, D-Y
    CANCER RESEARCH, 2011, 71
  • [42] RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 RESPONSE
    Ligibel, Jennifer A.
    Winer, Eric
    Hudis, Clifford A.
    Barry, William T.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01):
  • [43] Concordance of PAM50 molecular subtyping between oligonucleotide microarray and nanoString nCounter assay for Taiwanese breast cancer
    Huang, Chi-Cheng
    Tu, Chao-Chiang
    Tsai, Mong-Hsun
    Lai, Liang-chuan
    Huang, Ching-Shui
    CANCER RESEARCH, 2020, 80 (16)
  • [44] PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study
    Balle, Judith Katharina
    Vetter, Martina
    Kenea, Tariku Wakuma
    Eber-Schulz, Pia
    Reibold, Christian
    Ziegenhorn, Hannes-Viktor
    Stueckrath, Kathrin
    Wickenhauser, Claudia
    Addissie, Adamu
    Santos, Pablo
    Kantelhardt, Eva Johanna
    Getachew, Sefonias
    Bauer, Marcus
    BMC CANCER, 2024, 24 (01)
  • [45] Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes
    Santonja, Angela
    Sanchez-Munoz, Alfonso
    Fernandez, Yessica Plata
    Miramon, Jose
    Zarcos, Irene
    Perez, Casilda Llacer
    de Luque, Vanessa
    Fernandez-Sousa, Cristina
    Jerez, Jose Manuel
    Alvarez, Martina
    Vicioso, Luis
    Alba, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ohara, Ako Matsushita
    Naoi, Yasuto
    Shimazu, Kenzo
    Kagara, Naofumi
    Shimoda, Masafumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 533 - 543
  • [47] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ako Matsushita Ohara
    Yasuto Naoi
    Kenzo Shimazu
    Naofumi Kagara
    Masafumi Shimoda
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2019, 173 : 533 - 543
  • [48] Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
    Prat, Aleix
    Bianchini, Giampaolo
    Thomas, Marlene
    Belousov, Anton
    Cheang, Maggie C. U.
    Koehler, Astrid
    Gomez, Patricia
    Semiglazov, Vladimir
    Eiermann, Wolfgang
    Tjulandin, Sergei
    Byakhow, Mikhail
    Bermejo, Begona
    Zambetti, Milvia
    Vazquez, Federico
    Gianni, Luca
    Baselga, Jose
    CLINICAL CANCER RESEARCH, 2014, 20 (02) : 511 - 521
  • [49] Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
    Jorgensen, C. L. T.
    Nielsen, T. O.
    Bjerre, K. D.
    Liu, S.
    Wallden, B.
    Balslev, E.
    Nielsen, D. L.
    Ejlertsen, B.
    CANCER RESEARCH, 2012, 72
  • [50] Race and age differences in PAM50 biomarker status in the Carolina breast cancer study
    Troester, M. A.
    Sun, X.
    Allott, E. H.
    Kit, C-K
    Thorne, L.
    Mathews, M.
    Cohen, S. M.
    Geradts, J.
    Kirk, E.
    Li, Y.
    Hu, Z.
    Robinson, W.
    Hoadley, K. A.
    Reeder-Hayes, K.
    Earp, S.
    Olshan, A. F.
    Carey, L. A.
    Perou, C. M.
    CANCER RESEARCH, 2017, 77